News

Zacks Investment Research on MSN9h
AstraZeneca Stock Declines 6% in 3 Months: Time to Buy the Dip?
AstraZeneca AZN stock has declined 6.4% in the past three months. Although AstraZeneca faces its share of challenges, a ...
Livewire Markets16h
Moving beyond founder-led
We have been reading a few articles recently from Australian funds managers regarding the benefits of investing in “founder ...
Zacks Investment Research on MSN10h
AMGN Down 10% in 3 Months: How to Play the Stock as Tariff Woes Linger
Amgen’s AMGN stock has declined 10.4% in the past three months. A lot of this price decline is related to the broader ...
Morningstar22h
Company Reports
This makes us uneasy. In the near term, buying the stock feels like a coin flip, where trading will be dependent simply on how the Grand Theft Auto VI release, due in spring 2026, performs ...